MOLDTKPAC Q4 FY26 Earnings Call Transcript & Analysis
Pharma Sales ₹34 cr (+219% YoY); Overall Sales Growth 0.134%; EBITDA per kg ₹40.7 (+8% YoY). Pharma packaging sales grew 219% in FY26 to INR34.4 crores.
Read full transcript & analysis
Every earnings call for MOLDTKPAC — management tone, guidance, KPIs and promise tracking, quarter by quarter.
MOLDTKPAC · 5 transcripts · Capital Goods · latest Q4 FY26Pharma Sales ₹34 cr (+219% YoY); Overall Sales Growth 0.134%; EBITDA per kg ₹40.7 (+8% YoY). Pharma packaging sales grew 219% in FY26 to INR34.4 crores.
Read full transcript & analysis9M FY26 Sales Value Growth 0.12% (+12% YoY); 9M FY26 EBITDA Growth 0.2% (+20% YoY); Q3 FY26 Sales Volume Growth 0.06% (+6% YoY). 9M FY26 EBITDA up 20% YoY, sales value up 12% YoY.
Read full transcript & analysisSales Value Growth 0.0965% (+10% YoY); Volume Growth 0.07% (+7% YoY); H1 EBITDA per kg ₹40.6 (+10% YoY). Q2 FY26 sales value up 9.65% and volume up 7% YoY.
Read full transcript & analysisEBITDA Margin 19.7%. Revenue up 22% YoY.
Read full transcript & analysisSales Growth 0.118%; Volume Growth 0.073%; EBITDA Growth 0.07%. Pharma division achieved break-even in Q4 FY25, with turnover jumping from ₹2.5 crores in Q3 to ₹6.7 crores in Q4.
Read full transcript & analysis